Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The daunting challenge of keeping HIV suppressed.

× No keyword cloud information.

12 in total

1. A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.

Authors: S Druillennec; C Z Dong; S Escaich; N Gresh; A Bousseau; B P Roques; M C Fournié-Zaluski
Journal: Proc Natl Acad Sci U S A Date: 1999-04-27 Impact factor: 11.205

2. Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity.

Authors: E K Halvas; E S Svarovskaia; V K Pathak
Journal: J Virol Date: 2000-01 Impact factor: 5.103

3. The cellular HIV-1 Rev cofactor hRIP is required for viral replication.

Authors: Zhong Yu; Nuria Sánchez-Velar; Irina E Catrina; Ellen L W Kittler; Enyeneama B Udofia; Maria L Zapp
Journal: Proc Natl Acad Sci U S A Date: 2005-03-04 Impact factor: 11.205

Review 4. The new antiretroviral "cocktails": is the stage set for HIV-positive women to benefit?

Authors: S Walmsley
Journal: CMAJ Date: 1998-02-10 Impact factor: 8.262

5. Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcription.

Authors: J A Turpin; R W Buckheit; D Derse; M Hollingshead; K Williamson; C Palamone; M C Osterling; S A Hill; L Graham; C A Schaeffer; M Bu; M Huang; W M Cholody; C J Michejda; W G Rice
Journal: Antimicrob Agents Chemother Date: 1998-03 Impact factor: 5.191

6. Wild-type and YMDD mutant murine leukemia virus reverse transcriptases are resistant to 2',3'-dideoxy-3'-thiacytidine.

Authors: E K Halvas; E S Svarovskaia; E O Freed; V K Pathak
Journal: J Virol Date: 2000-07 Impact factor: 5.103

7. Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.

Authors: Jia Ma; Suzanne Kennedy-Stoskopf; Jesse M Jaynes; Linda M Thurmond; Wayne A Tompkins
Journal: J Virol Date: 2002-10 Impact factor: 5.103

8. Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications.

Authors: W K Wang; T Dudek; M Essex; T H Lee
Journal: Proc Natl Acad Sci U S A Date: 1999-04-13 Impact factor: 11.205

9. A molecular modeling study of inhibitors of nuclear factor kappa-B (p50)--DNA binding.

Authors: Vineet Pande; Rakesh K Sharma; Jun-Ichiro Inoue; Masami Otsuka; Maria J Ramos
Journal: J Comput Aided Mol Des Date: 2003-12 Impact factor: 3.686

10. FRET-based assay to screen inhibitors of HIV-1 reverse transcriptase and nucleocapsid protein.

Authors: Kamal K Sharma; Frédéric Przybilla; Tobias Restle; Julien Godet; Yves Mély
Journal: Nucleic Acids Res Date: 2016-01-13 Impact factor: 16.971